迈普医学：国寿成达拟减持不超1%股份

Core Viewpoint - China Life Chengda plans to reduce its stake in Maipu Medical by up to 670,500 shares, representing 1% of the total share capital, due to its own operational needs [1] Summary by Categories Shareholding Changes - The reduction will occur through centralized bidding transactions [1] - The reduction period is set for three months, starting from 15 trading days after the announcement date [1] - The reduction accounts for 1.0036% of the total share capital after excluding shares held in the company's repurchase special account [1]